-
Araya RE, Goldszmid RS, 2017: IFNAR1 degradation: a new mechanism for tumor immune evasion?[J]. Cancer Cell, 31, 161-163.
-
Castelló A, Alvarez E, Carrasco L, 2011: The multifaceted poliovirus 2A protease: regulation of gene expression by picornavirus proteases[J]. J Biomed Biotechnol, 2011, 369648-.
-
Chang YH, Lau KS, Kuo R, Horng JT, 2017: dsRNA binding domain of PKR is proteolytically released by enterovirus A71 to facilitate viral replication[J]. Front Cell Infect Microbiol, 7, 284-.
-
Chow KT, Gale M Jr, 2015: SnapShot: interferon signaling[J]. Cell, 163, 1808-.
-
Deszcz L, Seipelt J, Vassilieva E, Roetzer A, Kuechler E, 2004: Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase[J]. FEBS Lett, 560, 51-55.
-
Duan H, Zhu M, Xiong Q, Wang Y, Xu C, Sun J, Wang C, Zhang H, Xu P, Peng Y, 2017: Regulation of enterovirus 2A proteaseassociated viral IRES activities by the cell's ERK signaling cascade: implicating ERK as an efficiently antiviral target[J]. Antiviral Res, 143, 13-21.
-
Fuchs SY, 2013: Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy[J]. J Interferon Cytokine Res, 33, 211-225.
-
Hsu YY, Liu YN, Lu WW, Kung SH, 2009: Visualizing and quantifying the differential cleavages of the eukaryotic translation initiation factors eIF4GI and eIF4GII in the enterovirusinfected cell[J]. Biotechnol Bioeng, 104, 1142-1152.
-
Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF, 1999: Neurologic complications in children with enterovirus 71 infection[J]. N Engl J Med, 341, 936-942.
-
Huang J, Liao Q, Ooi MH, Cowling BJ, Chang Z, Wu P, Liu F, Li Y, Luo L, Yu S, Yu H, Wei S, 2018: Epidemiology of recurrent hand, foot and mouth disease, China, 2008-2015[J]. Emerg Infect Dis, 24, 432-442.
-
Hung HC, Wang HC, Shih SR, Teng IF, Tseng CP, Hsu JT, 2011: Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir[J]. J Infect Dis, 203, 1784-1790.
-
Jin Y, Zhang R, Wu W, Duan G, 2018: Innate immunity evasion by enteroviruses linked to epidemic hand-foot-mouth disease[J]. Front Microbiol, 9, 2422-.
-
Kuo RL, Kao LT, Lin SJ, Wang RY, Shih SR, 2013: MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation[J]. PLoS ONE, 8, e63431-.
-
Lee KM, Chen CJ, Shih SR, 2017: Regulation mechanisms of viral IRES-Driven translation[J]. Trends Microbiol, 25, 546-561.
-
Lee JY, Son M, Kang JH, Choi UY, 2018: Serum interleukin-6 levels as an indicator of aseptic meningitis among children with enterovirus 71-induced hand, foot and mouth disease[J]. Postgrad Med, 130, 258-263.
-
Li Y, Chang Z, Wu P, Liao Q, Liu F, Zheng Y, Luo L, Zhou Y, Chen Q, Yu S, Guo C, Chen Z, Long L, Zhao S, Yang B, Yu H, Cowling BJ, 2018: Emerging enteroviruses causing hand, foot and mouth disease, China, 2010-2016[J]. Emerg Infect Dis, 24, 1902-1906.
-
Liu Y, Zhang Z, Zhao X, Yu R, Zhang X, Wu S, Liu J, Chi X, Song X, Fu L, Yu Y, Hou L, Chen W, 2014: Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression[J]. Viral Immunol, 27, 267-276.
-
Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML, 2012: Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1[J]. J Virol, 86, 3767-3776.
-
Marissen WE, Lloyd RE, 1998: Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells[J]. Mol Cell Biol, 18, 7565-7574.
-
Morrison JM, Racaniello VR, 2009: Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells[J]. J Virol, 83, 4412-4422.
-
Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T, 2010: Clinical features, diagnosis, and management of enterovirus 71[J]. Lancet Neurol, 9, 1097-1105.
-
Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG, 2012: Crystal structure of human enterovirus 71[J]. Science, 336, 1274-.
-
Prévôt D, Darlix JL, Ohlmann T, 2003: Conducting the initiation of protein synthesis: the role of eIF4G[J]. Biol Cell, 95, 141-156.
-
Rasti M, Khanbabaei H, Teimoori A, 2019: An update on enterovirus 71 infection and interferon type I response[J]. Rev Med Virol, 29, e2016-.
-
Sadler AJ, Williams BR, 2008: Interferon-inducible antiviral effectors[J]. Nat Rev Immunol, 8, 559-568.
-
Schmidt NJ, Lennette EH, Ho HH, 1974: An apparently new enterovirus isolated from patients with disease of the central nervous system[J]. J Infect Dis, 129, 304-309.
-
Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH, 2010: Virology, epidemiology, pathogenesis, and control of enterovirus 71[J]. Lancet Infect Dis, 10, 778-790.
-
Song F, Yu X, Zhong T, Wang Z, Meng X, Li Z, Zhang S, Huo W, Liu X, Zhang Y, Zhang W, Yu J, 2018: Caspase-3 inhibition attenuates the cytopathic effects of EV71 infection[J]. Front Microbiol, 9, 817-.
-
Wang C, Zhou R, Zhang Z, Jin Y, Cardona CJ, Xing Z, 2015a: Intrinsic apoptosis and proinflammatory cytokines regulated in human astrocytes infected with enterovirus 71[J]. J Gen Virol, 96, 3010-3022.
-
Wang CY, Huang AC, Hour MJ, Huang SH, Kung SH, Chen CH, Chen IC, Chang YS, Lien JC, Lin CW, 2015b: Antiviral potential of a novel compound CW-33 against enterovirus A71 via inhibition of viral 2A protease[J]. Viruses, 7, 3155-3171.
-
Wang H, Li Y, 2019: Recent Progress on Functional Genomics Research of Enterovirus 71[J]. Virol Sin, 34, 9-21.
-
Wang C, Sun M, Yuan X, Ji L, Jin Y, Cardona CJ, Xing Z, 2017: Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-a1 degradation[J]. J Biol Chem, 292, 10262-10274.
-
Yu H, Cowling BJ, 2019: Remaining challenges for prevention and control of hand, foot, and mouth disease[J]. Lancet Child Adolesc Health, 3, 373-374.
-
Yuan J, Shen L, Wu J, Zou X, Gu J, Chen J, Mao L, 2018: Enterovirus A71 proteins: structure and function[J]. Front Microbiol, 9, 286-.
-
Zamora M, Marissen WE, Lloyd RE, 2002: Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells[J]. J Virol, 76, 165-177.
-
Zhang H, Feng H, Luo L, Zhou Q, Luo Z, Peng Y, 2010: Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2[J]. Virus Res, 150, 22-27.
-
Zhang Y, Li J, Li Q, 2018: Immune evasion of enteroviruses under innate immune monitoring[J]. Front Microbiol, 9, 1866-.
-
Zhu M, Duan H, Gao M, Zhang H, Peng Y, 2015: Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication[J]. Viruses, 7, 1344-1356.